Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.

ORDER

Plaintiffs-Appellees ARIAD Pharmaceuticals, Inc., et al. filed a petition for rehearing en banc. The petition for rehearing en banc was presumed to request relief that can be granted by the panel that heard the appeal, and action on the petition for rehearing en banc was deferred until the panel had an opportunity to grant the relief requested. The panel requested a response from Defendant-Appellant Eli Lilly and Company, who filed a response. The court granted Novozymes A/S’s motion for leave to file a brief as amicus curiae.

The petition for rehearing was considered by the panel that…